Log in or Sign up for Free to view tailored content for your specialty!
Pulmonary Vascular Disease News
Inpatient palliative care for PAH low, but use increased in recent years
Use of palliative care services among inpatients with pulmonary arterial hypertension in the United States increased from 2001 to 2017, with a significant rise in the past decade, researchers reported in Chest.
Oral co-trimoxazole fails to reduce adverse outcomes in patients with IPF
Treatment with oral co-trimoxazole did not reduce time to death, lung transplant or nonelective hospitalization compared with placebo in patients with moderate or severe idiopathic pulmonary fibrosis in the EME-TIPAC trial.
Log in or Sign up for Free to view tailored content for your specialty!
Obesity, overweight worsen health-related quality of life in patients with PAH
Obesity and overweight were associated with worse health-related quality of life and increased risk for hospitalization in patients with pulmonary arterial hypertension, researchers reported in Annals of the American Thoracic Society.
Selexipag improves outcomes in connective tissue disease-associated PAH in real-world setting
Patients with connective tissue disease-associated pulmonary arterial hypertension benefit from selexipag treatment in the real-world setting, according to new data from the SPHERE analysis.
Aspiration system for PE receives expanded indication
Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded indication from the FDA.
Thoracic visceral adipose tissue linked to pulmonary hypertension in transplant candidates
In a new study, lower thoracic visceral adipose tissue was associated with elevated risk for pulmonary hypertension in patients with advanced lung disease undergoing evaluation for lung transplantation.
Markers identify pulmonary hypertension in combined pulmonary fibrosis, emphysema
Right inferior pulmonary vein diameter and left ventricular short axis diameter at diagnosis are associated with development of pulmonary hypertension development in patients with combined pulmonary fibrosis and emphysema.
Pulmonary hypertension may impact in-hospital mortality in acute COPD exacerbations
Pulmonary hypertension is associated with an increase in in-hospital mortality and other adverse outcomes in patients with acute exacerbation of COPD, researchers reported.
Inhaled formulation of vardenafil for as-needed use shows promise in PAH
An inhaled formulation of the PDE5 inhibitor vardenafil, in development for as-needed use for episodic symptoms of pulmonary arterial hypertension, yielded improvements in pulmonary hemodynamics, according to results of a phase 2a trial.
Pulmonary endarterectomy improves outcomes in patients with CTEPH
Patient-reported outcomes significantly improved after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension, or CTEPH, according to results published in the European Respiratory Journal.